glp-1 signaling pathway Glucagon-like peptide-1 Pancreas and Not Gut Mediates

A recent study from Johns Hopkins University researchers has raised questions about whether widely prescribed GLP-1 receptor agonists, including Ozempic, Wegovy, and Mounjaro, may be associated with an increased risk of dementia and Alzheimers disease

Bupropion's FDA label includes a warning that alcohol use increases seizure risk [3]

GLP-1 RAs also signal the fullness centers in your brain telling you to stop eating

GLP-1 RAs enhance autophagy in rodent models, facilitating the elimination of damaged mitochondria and increasing cellular resilience to stress

Status epilepticus: whats new for the intensivist

doi: 10.1080/13693780701435333